Recurrent Clostridium difficile infection occurred in 22.1% of patients using gastric acid suppression medications, compared with 17.3% of patients not using such medications.
Notes on verification
Directly confirmed by peer-reviewed JAMA Internal Medicine meta-analysis (Tariq et al., 2017), with exact figures corroborated by PubMed abstract and multiple independent medical news outlets. [tier=gold indep_score=0.983 clusters=3 claim_tier=notable]
Sources
- Gastric acid suppression medications increase risk for recurrence of ... (seed:health_and_medicine)
- https://pubmed.ncbi.nlm.nih.gov/28346595/ (corroboration)
- https://www.pharmaceutical-journal.com/news-and-analysis/news/gastric-acid-drugs-linked-to-increased-risk-of-clostridium-difficile-infection/20202518.article (corroboration)
- https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2612117 (corroboration)